Jiangxi University of Traditional Chinese Medicine
14
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Bushen Yiqi Formula Combined With Dehydroepiandrosterone in Women With Diminished Ovarian Reserve
Role: lead
Safety Evaluation of Pueraria Lobata Radix in Specific Consumption Scenarios for Type 2 Diabetes
Role: lead
Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus
Role: lead
Efficacy and Safety of Electroacupuncture on Lumbar Disc Herniation with Radiculopathy
Role: lead
A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community
Role: lead
Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases
Role: lead
Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia
Role: lead
Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome
Role: lead
Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome
Role: lead
Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome
Role: lead
Green Tea Extract for Endometriosis Treatment
Role: collaborator
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer
Role: lead
Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial
Role: lead
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Non-organic Gastrointestinal Disorders
Role: lead
All 14 trials loaded